Kontaktieren Sie uns

Wir sind für Sie da

Arzt & Praxis
Mo – Do:
8:00-13:00 und 14:00-17:00
Fr:
8:00-13:00 und 14:00-15:00

Patientinnen
Mo – Do:
9:00-11:00 und 14:30-17:00
Fr: 9:00-12:00

Eurofins LifeCodexx GmbH

Pioneering non-invasive prenatal testing in Europe

In Germany, since 2010, we have developed prenatal genetic tests of the highest quality which allow women to be informed at an early point in their pregnancy and make independent decisions.

Pioneering non-invasive prenatal testing in Europe

In Germany, since 2010, we have developed prenatal genetic tests of the highest quality which allow women to be informed at an early point in their pregnancy and make independent decisions. For this reason, we work closely with gynecologists, prenatal medicine specialists, human geneticists and scientific experts in Germany to provide women concerned with the best possible support. Since the start of 2018, LifeCodexx has belonged to Eurofins Scientific, a leading international laboratory group, and has strengthened the technology portfolio of the Clinical Diagnostics business unit.

In 2012 the PrenaTest® was launched on the market as Europe’s first NIPT. It has now become firmly established in many gynecological practices as a reliable, fast and safe test method.

PrenaTest® – Europe’s first NIPT brought about a lasting change to prenatal diagnostics

In 2013, we submitted applications for NIPT to be covered by health insurance. The Joint National Committee of Germany (G-BA) has now decided: Perhaps as early as the fall of 2020, NIPT will be paid for by health insurance companies and included in the German Maternity Guidelines. Please also read our press release.

We give clarity

All of our work is focused on providing expectant women with reliable and safe genetic tests that enable them to make informed and self-determined decisions at an early point in their pregnancies.


NIPT pioneer in Europe

Since 2010 we have been developing clinically validated, non-invasive genetic tests. Two years later, we launched PrenaTest®, the first non-invasive prenatal test (NIPT) in Europe. At that time it could determine trisomy 21, which leads to the Down syndrome. Now the PrenaTest® is able examine the complete set of fetal chromosomes for possible changes. Of course, we will also endeavor to remain at the forefront of this field well into the future.


Become our strategic partner

Are you interested in a strategic partnership with us? Please get in touch with us.


Contact

Thank you for contacting us. We are looking forward to your message.

Contact